Cargando…

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas

Detalles Bibliográficos
Autor principal:	Segura, Marcos Emanuel de Alcântara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418615/ https://www.ncbi.nlm.nih.gov/pubmed/30786311 http://dx.doi.org/10.1055/s-0039-1678591

Ejemplares similares

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
por: Zeferino, Luiz Carlos, et al.
Publicado: (2018)

Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China
por: Li, Zhi-Fang, et al.
Publicado: (2022)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)

Cervical Cancer Screening with HPV Testing: Updates on the Recommendation
por: Carvalho, Carla Fabrine, et al.
Publicado: (2022)

Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
por: Branković, Ivan, et al.
Publicado: (2013)

Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria
por: Modibbo, Fatima, et al.
Publicado: (2017)

Cervical cancer screening by visual inspection and HPV testing in Eswatini
por: Ginindza, Themba G., et al.
Publicado: (2022)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

HPV-based cervical cancer screening in Nicaragua: from testing to treatment
por: Holme, Francesca, et al.
Publicado: (2020)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Clinical significance of HPV-DNA testing for precancerous cervical lesionS
por: Moarcăs, M, et al.
Publicado: (2014)

Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing
por: Vorsters, Alex, et al.
Publicado: (2016)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening
por: Hoste, G., et al.
Publicado: (2013)

Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
por: Chrysostomou, Andreas C., et al.
Publicado: (2020)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening
por: Yang, Qing, et al.
Publicado: (2022)

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
por: Chrysostomou, Andreas C., et al.
Publicado: (2018)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
por: Wei, Baojun, et al.
Publicado: (2020)

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
por: Arbyn, Marc, et al.
Publicado: (2022)

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening
por: Iacobellis, Michela, et al.
Publicado: (2018)

Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method
por: Zhao, Fang-Hui, et al.
Publicado: (2012)

Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana
por: Dei-Adomakoh, Yvonne, et al.
Publicado: (2023)

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
por: Gustavsson, Inger, et al.
Publicado: (2019)

Opportunities and challenges for introducing HPV testing for cervical cancer screening in sub-Saharan Africa
por: Tsu, Vivien Davis, et al.
Publicado: (2018)

High risk HPV testing for cervical cancer screening in a Puerto Rican population
por: Gustafson, Erik A., et al.
Publicado: (2023)

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019)

Social and psychological impact of HPV testing in cervical screening: a qualitative study
por: McCaffery, K, et al.
Publicado: (2006)

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Cervical Cancer Screening for the Reluctant - HPV Testing of Air-Dried Vaginal Discharge
por: Tong, Tommy R., et al.
Publicado: (2006)

Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China
por: Thomsen, Louise T., et al.
Publicado: (2021)

Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project()
por: Holme, Francesca, et al.
Publicado: (2020)

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
por: Anttila, Ahti, et al.
Publicado: (2010)

HPV immunohistochemical testing and cervical dysplasia
por: MUREŞAN, DANIEL, et al.
Publicado: (2016)

Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece
por: Skroumpelos, Anastasios, et al.
Publicado: (2019)

Cervical Cancer Screening with DNA-HPV Testing and Precancerous Lesions Detection: A Brazilian Population-based Demonstration Study
por: Teixeira, Julio Cesar, et al.
Publicado: (2023)

Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma
por: Costa, Silvano, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nr6mbsak0bsi9fd6c1vnr9umon